Hyperfine (HYPR) Competitors $0.76 -0.04 (-4.38%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$0.77 +0.00 (+0.26%) As of 07/7/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. NVRO, SGHT, BSGM, TLSI, INGN, ELMD, PROF, KRMD, CVRX, and LNSRShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Nevro (NVRO), Sight Sciences (SGHT), Biosig Technologies (BSGM), TriSalus Life Sciences (TLSI), Inogen (INGN), Electromed (ELMD), Profound Medical (PROF), KORU Medical Systems (KRMD), CVRx (CVRX), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors Nevro Sight Sciences Biosig Technologies TriSalus Life Sciences Inogen Electromed Profound Medical KORU Medical Systems CVRx LENSAR Nevro (NYSE:NVRO) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations. Does the media favor NVRO or HYPR? In the previous week, Nevro and Nevro both had 1 articles in the media. Nevro's average media sentiment score of 0.00 equaled Hyperfine'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nevro 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hyperfine 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in NVRO or HYPR? 95.5% of Nevro shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 3.2% of Nevro shares are owned by company insiders. Comparatively, 31.0% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher earnings and valuation, NVRO or HYPR? Hyperfine has lower revenue, but higher earnings than Nevro. Nevro is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNevro$408.52M0.55-$92.21M-$3.05-1.92Hyperfine$12.89M4.62-$40.72M-$0.54-1.42 Is NVRO or HYPR more profitable? Nevro has a net margin of -16.54% compared to Hyperfine's net margin of -343.42%. Nevro's return on equity of -23.52% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Nevro-16.54% -23.52% -10.83% Hyperfine -343.42%-74.19%-62.40% Which has more volatility & risk, NVRO or HYPR? Nevro has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Do analysts rate NVRO or HYPR? Nevro presently has a consensus target price of $5.36, indicating a potential downside of 8.29%. Hyperfine has a consensus target price of $1.06, indicating a potential upside of 38.56%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nevro 2 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.92Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryHyperfine beats Nevro on 9 of the 14 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.27M$6.86B$5.52B$9.02BDividend YieldN/A1.21%5.24%4.08%P/E Ratio-1.4225.5527.1920.04Price / Sales4.62111.05413.81108.84Price / CashN/A21.4826.2128.59Price / Book1.144.727.925.55Net Income-$40.72M$173.18M$3.17B$248.49M7 Day Performance11.29%0.34%1.78%4.87%1 Month Performance-3.92%-2.74%1.26%6.63%1 Year Performance-23.19%25.56%33.30%20.38% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine1.8401 of 5 stars$0.77-4.4%$1.06+38.6%-23.5%$62.27M$12.89M-1.42190Gap DownNVRONevro0.1757 of 5 stars$5.85+0.1%$5.36-8.3%-32.1%$224.32M$408.52M-3.091,090SGHTSight Sciences1.3617 of 5 stars$4.13-4.0%$4.10-0.7%-44.0%$222.29M$79.87M-4.21210News CoverageBSGMBiosig Technologies0.2674 of 5 stars$7.14-6.8%$10.00+40.1%+2,718.4%$209.08M$40K0.0050Gap UpTLSITriSalus Life Sciences2.6126 of 5 stars$5.45+2.4%$10.75+97.2%-14.6%$201.30M$29.43M-4.87106High Trading VolumeINGNInogen4.3835 of 5 stars$7.03-0.7%$11.00+56.5%-12.0%$190.36M$335.70M-6.111,030ELMDElectromed1.4762 of 5 stars$21.99flat$38.00+72.8%+41.6%$184.41M$61.44M29.32160PROFProfound Medical2.6542 of 5 stars$5.90-1.7%$11.50+94.9%-31.6%$180.32M$10.68M-4.84150KRMDKORU Medical Systems2.1792 of 5 stars$3.58-1.4%$4.50+25.7%+45.6%$167.49M$33.65M-32.5580News CoveragePositive NewsHigh Trading VolumeCVRXCVRx2.7127 of 5 stars$5.88+1.0%$14.50+146.6%-46.7%$151.74M$51.29M-2.70160Positive NewsLNSRLENSAR1.3568 of 5 stars$13.17+3.2%$15.00+13.9%+187.2%$150.47M$53.49M-2.72110 Related Companies and Tools Related Companies Nevro Alternatives Sight Sciences Alternatives Biosig Technologies Alternatives TriSalus Life Sciences Alternatives Inogen Alternatives Electromed Alternatives Profound Medical Alternatives KORU Medical Systems Alternatives CVRx Alternatives LENSAR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HYPR Stock Alerts